The weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.
Morphological and physiological development of FETUSES.
The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease.
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.
The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.
The failure of a FETUS to attain its expected FETAL GROWTH at any GESTATIONAL AGE.
A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).
The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation.
A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.
Increase in BODY WEIGHT over existing weight.
The use of statistical and mathematical methods to analyze biological observations and phenomena.
Morphological and physiological development of EMBRYOS or FETUSES.
Decrease in existing BODY WEIGHT.
The number of offspring produced at one birth by a viviparous animal.
The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.
The measurement of an organ in volume, mass, or heaviness.
An infant during the first month after birth.
The sum of the weight of all the atoms in a molecule.
Specialized arterial vessels in the umbilical cord. They carry waste and deoxygenated blood from the FETUS to the mother via the PLACENTA. In humans, there are usually two umbilical arteries but sometimes one.
The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.
Disorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.
A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS).
Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery.
The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation.
The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS).
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.
The condition of carrying TWINS simultaneously.
The circulation of BLOOD, of both the mother and the FETUS, through the PLACENTA.
A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
That portion of the body that lies between the THORAX and the PELVIS.
The potential of the FETUS to survive outside the UTERUS after birth, natural or induced. Fetal viability depends largely on the FETAL ORGAN MATURITY, and environmental conditions.
In utero measurement corresponding to the sitting height (crown to rump) of the fetus. Length is considered a more accurate criterion of the age of the fetus than is the weight. The average crown-rump length of the fetus at term is 36 cm. (From Williams Obstetrics, 18th ed, p91)
One of a pair of irregularly shaped quadrilateral bones situated between the FRONTAL BONE and OCCIPITAL BONE, which together form the sides of the CRANIUM.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
An agent that causes the production of physical defects in the developing embryo.
A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more.
The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.
Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.
A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.
An infant having a birth weight lower than expected for its gestational age.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.
The portion of the leg in humans and other animals found between the HIP and KNEE.
The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.
The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.
Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.
Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.
The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC).
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
The longest and largest bone of the skeleton, it is situated between the hip and the knee.
Nutrition of a mother which affects the health of the FETUS and INFANT as well as herself.
Pregnancy in which the mother and/or FETUS are at greater than normal risk of MORBIDITY or MORTALITY. Causes include inadequate PRENATAL CARE, previous obstetrical history (ABORTION, SPONTANEOUS), pre-existing maternal disease, pregnancy-induced disease (GESTATIONAL HYPERTENSION), and MULTIPLE PREGNANCY, as well as advanced maternal age above 35.
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.

Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring. (1/309)

Increasing evidence from human epidemiological studies suggests that poor growth before birth is associated with postnatal growth retardation and the development of cardiovascular disease in adulthood. We have shown previously that nutritional deprivation in the pregnant rat leads to intrauterine growth retardation (IUGR), postnatal growth failure, changes in the endocrine parameters of the somatotrophic axis, and to increased blood pressure in later life. In the present study, we investigated whether administration of insulin-like growth factor-I (IGF-I) or bovine growth hormone (GH) during pregnancy could prevent IUGR and/or alter long-term outcome. Dams from day 1 of pregnancy throughout gestation received a diet of ad libitum available food or a restricted dietary intake of 30% of ad libitum fed dams. From day 10 of gestation, dams were treated for 10 days with three times daily subcutaneous injections of saline (100 microl), IGF-I (2 micrograms/g body weight) or GH (2 micrograms/g body weight). Maternal weight gain was significantly increased (P<0.001) in ad libitum fed dams treated with GH, (98.9+/-4.73 g) compared with the IGF-I (80.5+/-2.17 g) and saline-treated (70.7+/-2.65 g) groups. There was a small increase in maternal weight gain (P<0.06) in 30% ad libitum fed dams following GH (16.3+/-2.47 g) and IGF-I (15.8+/-1.97 g) treatment compared with saline (9.2+/-1.96 g). Whole spleen, kidney and carcass weights were significantly (P<0.05) increased in ad libitum fed and 30% ad libitum fed dams with GH treatment. Circulating IGF-I was significantly increased (P<0.001) in ad libitum fed dams with both IGF-I (369.6+/-32.33 ng/ml) and GH (457.9+/-33.32 ng/ml) compared with saline treatment (211.7+/-14.02 ng/ml), and with GH (223.4+/-23.72 ng/ml) compared with saline treatment (112.0+/-7.33 ng/ml) in 30% ad libitum fed dams. Circulating GH binding protein (GHBP) levels were significantly reduced (P<0.05) in GH-treated (299.1+/-51.54 ng/ml) compared with saline-treated (503.9+/-62.43 ng/ml) ad libitum fed dams, but were not altered in 30% ad libitum fed dams. There was no significant effect of either IGF-I or GH treatment on fetal weight, placental weight, fetal organ weights or circulating IGF-I levels in both ad libitum fed and 30% ad libitum fed fetuses. Offspring of 30% ad libitum fed dams remained significantly growth retarded postnatally and showed elevated blood pressure in later life. The increased maternal weight gain following IGF-I or GH administration, without an effect on fetal and placental weights, suggests a modification in the mode of maternal nutrient repartitioning during mid to late pregnancy at the expense of the fetus.  (+info)

Abundance of leptin mRNA in fetal adipose tissue is related to fetal body weight. (2/309)

Leptin mRNA was measured in adipose tissue of fetal sheep by reverse transcription polymerase chain reaction (RTPCR). Abundance of leptin mRNA relative to b-actin mRNA in fetal perirenal adipose tissue increased (P<0.02) with gestation, being higher at 144 d (0.73 +/- 0. 10, n=5) than at 90-91 d (0.40 +/- 0.08, n=6) or 125 d (0.40 +/- 0. 04, n=5) gestation (term approximately 147- 150 d). There was a positive relationship between relative abundance of leptin mRNA (y) and fetal body weight (x)between 90 and 144 d gestation (r 2 =0.27, P<0.01). The slope of the linear dependence of leptin mRNA on fetal weight was 15-fold greater (P<0.001) at 90-91d (y = 2.81x - 1.1, n=6, r 2 =0.71, P<0.025) than between 125-144 d gestation (y = 0.195x - 0.15, n=16, r 2 =0.39, P<0.01). Thus the leptin synthetic capacity of fetal adipose tissue appears to increase in late gestation but this is accompanied by constraint of its sensitivity to fetal body weight. We hypothesise that leptin synthesis in fetal adipose tissue is related to fetal nutrient supply and growth rate.  (+info)

Adaptation of pancreatic islet B-cells during the last third of pregnancy: regulation of B-cell function and proliferation by lactogenic hormones in rats. (3/309)

In rodents, placental lactogen (PL)-I is considered to be the first trigger to enhance pancreatic islet B-cell function, and after its secretion is diminished at mid-pregnancy, PL-II takes over this role. However, little information is available on the regulation of islet B-cell function and proliferation by lactogenic hormones during the last third of pregnancy. This was the focus of the present study using rats in which pregnancy was forcibly prolonged. This rat possesses unique characteristics in that PL-I is re-secreted during the prolonged period of pregnancy and the peak concentrations in maternal circulation are comparable with those observed during mid-pregnancy in normal-pregnancy rats. Pregnancy was prolonged by successive administration of pregnant mare's serum gonadotropin (30IU/rat, s.c. on day 12) and human chorionic gonadotropin (10IU/rat, i.v. on day 14). When the insulin secretory responses to 10mmol/l glucose in islets obtained from normal-pregnancy and prolonged-pregnancy rats were tested, each insulin secretory response correlated well with the values of plasma lactogenic activity throughout the period of pregnancy and lactation. Examination of B-cell proliferation in normal-pregnancy rats showed that 5-bromo-2'-deoxyuridine (BrdU) incorporation into dividing B-cells reached a maximum on day 15 and then decreased markedly towards term. No increase in B-cell proliferation was observed on day 19 when plasma lactogenic activity reached the maximum. In prolonged-pregnancy rats, BrdU incorporation also continued to decrease as observed in normal-pregnancy rats after day 15, and then no enhancement in B-cell proliferation was observed even when the plasma lactogenic activity, including re-secreted PL-I, reached maximum. These results suggest that, in the last third of pregnancy, B-cell proliferation is no longer stimulated by lactogenic hormones in contrast to the insulin secretory response which is sustained.  (+info)

Protective effects of garlic juice against embryotoxicity of methylmercuric chloride administered to pregnant Fischer 344 rats. (4/309)

In order to investigate the beneficial effects of 0.5 or 1.0 g/kg Korean garlic juice against the embryotoxicity of 20 mg/kg methylmercury chloride (MMC, CH3HgCl), pregnant Fisher 344 rats were simultaneously orally administered on day 7 of gestation. On day 20 of gestation the dams were laparotomized under ether anesthesia, and the fetuses were removed and examined for toxicity of methylmercury. Garlic juice depressed the toxicity in terms of some parameters. In the case of simultaneous treatment with 0.1 g/kg garlic juice and MMC, rates of increase were 17.5% in maternal body weight, 13.2% and 41.9% in fetal and litters' weight respectively, and 37.0% in fetal survival rate. Decreasing rates were 10.0% in maternal death rate, and 6.9% and 31.3% in pre- and post-implantation loss respectively. Decreasing rates of mercury levels in dams were 67.2% in liver, 57.6% in brain, 47.2% in kidney, 42.1% in spleen and 40.9% in blood. As well, decreasing rates of mercury level in fetuses were 54.9% in all body burden, 55.9% in liver, 46.7% in kidney and 37% in brain, respectively. The number of fetal ossification centers were reduced by 23.8% to 58.0% following simultaneous treatment with 1.0 g/kg garlic juice. These findings indicated that garlic juice effectively inhibited the embryotoxicity of methylmercury in pregnant Fischer 344 rats.  (+info)

Abundance of leptin mRNA in fetal adipose tissue is related to fetal body weight. (5/309)

Leptin mRNA was measured in adipose tissue of fetal sheep by reverse transcription polymerase chain reaction (RTPCR). Abundance of leptin mRNA relative to beta-actin mRNA in fetal perirenal adipose tissue increased (P<0.02) with gestation, being higher at 144 d (0.73+/-0. 10, n=5) than at 90-91 d (0.40 +/- 0.08, n=6) or 125 d (0.40 +/- 0. 04, n=5) gestation (term approximately 147- 150 d). There was a positive relationship between relative abundance of leptin mRNA (y) and fetal body weight (x) between 90 and 144 d gestation (r(2) =0.27, P<0.01). The slope of the linear dependence of leptin mRNA on fetal weight was 15-fold greater (P<0.001) at 90-91d (y = 2.81x - 1.1, n=6, r(2) =0.71, P<0.025) than between 125-144 d gestation (y = 0.195x - 0.15, n=16, r(2) =0.39, P<0.01). Thus the leptin synthetic capacity of fetal adipose tissue appears to increase in late gestation but this is accompanied by constraint of its sensitivity to fetal body weight. We hypothesise that leptin synthesis in fetal adipose tissue is related to fetal nutrient supply and growth rate.  (+info)

Estimation of fetal weight: mean value from multiple formulas. (6/309)

Mean fetal weight value from multiple formulas was compared to fetal weight from single formulas. Data were collected on 975 fetuses who had estimation of fetal weight by ultrasonography within 1 week before birth. Improvement in estimation of fetal weight occurred using either the mean value of multiple formulas or the Hadlock BPD/FL/AC, in comparison to fetal volume, BPD/AC, or FL/AC. BPD/FL/AC appeared to provide the best estimate of true weight in terms of overall accuracy and in terms of not showing a trend in either overestimating or underestimating true weight.  (+info)

Preimplantation access to maternal insulin and albumin increases fetal growth rate in mice. (7/309)

Provision of the maternal factors, albumin and/or insulin to embryos in vitro restores preimplantation morphological development and cell proliferation to that seen in vivo. The hypothesis that the preimplantation effects of insulin or albumin would be reflected in increased fetal growth rate was examined. Two-cell embryos were cultured 48-50 h in medium supplemented with 0.17 micromol/l, 15 micromol/l albumin or 0.17 micromol/l insulin and the resultant blastocysts transferred to pseudopregnant recipients. Fetal and placental mass and skeletal development were determined at E19 or E20 (day 19 or 20 of embryonic development). Preimplantation access to insulin or albumin increased fetal growth by 4-6%. Combining insulin and albumin did not produce a further increment in fetal growth. The fetal growth achieved by providing preimplantation access to insulin, albumin or both was equivalent to that of in-vivo developed blastocysts. The conclusions are that: (i) preimplantation access to maternal insulin and albumin is required for normal fetal growth rates in the mouse and (ii) the increments in inner cell mass cell number and metabolic rates induced by insulin (and possibly albumin) reflect a requirement for maternal growth factors during preimplantation stages to optimize fetal development.  (+info)

A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. (8/309)

Valproate (VPA) is one of several effective anti-epileptic and mood-stabilizing drugs, many of which are also potent teratogens in humans and several other mammalian species. Variable teratogenicity among inbred strains of laboratory mice suggests that genetic factors influence susceptibility. While studying the genetic basis for VPA teratogenicity in mice, we discovered that parental factors influence fetal susceptibility to induced malformations. Detailed examination of these malformations revealed that many were homeotic transformations. To test whether VPA, like retinoic acid (RA), alters HOX expression, pluripotent human embryonal carcinoma cells were treated with VPA or RA and Hox expression assessed. Altered expression of specific Hox genes may thus account for the homeotic transformations and other malformations found in VPA-treated fetuses.  (+info)

Fetal weight is the calculated weight of a fetus during pregnancy, typically estimated through ultrasound measurements. It is a crucial indicator of fetal growth and development throughout pregnancy. The weight is determined by measuring various parameters such as the head circumference, abdominal circumference, and femur length, which are then used in conjunction with specific formulas to estimate the fetal weight. Regular monitoring of fetal weight helps healthcare providers assess fetal health, identify potential growth restrictions or abnormalities, and determine appropriate delivery timing. Low fetal weight can indicate intrauterine growth restriction (IUGR), while high fetal weight might suggest macrosomia, both of which may require specialized care and management.

Fetal development is the process in which a fertilized egg grows and develops into a fetus, which is a developing human being from the end of the eighth week after conception until birth. This complex process involves many different stages, including:

1. Fertilization: The union of a sperm and an egg to form a zygote.
2. Implantation: The movement of the zygote into the lining of the uterus, where it will begin to grow and develop.
3. Formation of the embryo: The development of the basic structures of the body, including the neural tube (which becomes the brain and spinal cord), heart, gastrointestinal tract, and sensory organs.
4. Differentiation of tissues and organs: The process by which different cells and tissues become specialized to perform specific functions.
5. Growth and maturation: The continued growth and development of the fetus, including the formation of bones, muscles, and other tissues.

Fetal development is a complex and highly regulated process that involves the interaction of genetic and environmental factors. Proper nutrition, prenatal care, and avoidance of harmful substances such as tobacco, alcohol, and drugs are important for ensuring healthy fetal development.

Prenatal ultrasonography, also known as obstetric ultrasound, is a medical diagnostic procedure that uses high-frequency sound waves to create images of the developing fetus, placenta, and amniotic fluid inside the uterus. It is a non-invasive and painless test that is widely used during pregnancy to monitor the growth and development of the fetus, detect any potential abnormalities or complications, and determine the due date.

During the procedure, a transducer (a small handheld device) is placed on the mother's abdomen and moved around to capture images from different angles. The sound waves travel through the mother's body and bounce back off the fetus, producing echoes that are then converted into electrical signals and displayed as images on a screen.

Prenatal ultrasonography can be performed at various stages of pregnancy, including early pregnancy to confirm the pregnancy and detect the number of fetuses, mid-pregnancy to assess the growth and development of the fetus, and late pregnancy to evaluate the position of the fetus and determine if it is head down or breech. It can also be used to guide invasive procedures such as amniocentesis or chorionic villus sampling.

Overall, prenatal ultrasonography is a valuable tool in modern obstetrics that helps ensure the health and well-being of both the mother and the developing fetus.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

Birth weight refers to the first weight of a newborn infant, usually taken immediately after birth. It is a critical vital sign that indicates the baby's health status and is used as a predictor for various short-term and long-term health outcomes.

Typically, a full-term newborn's weight ranges from 5.5 to 8.8 pounds (2.5 to 4 kg), although normal birth weights can vary significantly based on factors such as gestational age, genetics, maternal health, and nutrition. Low birth weight is defined as less than 5.5 pounds (2.5 kg), while high birth weight is greater than 8.8 pounds (4 kg).

Low birth weight babies are at a higher risk for various medical complications, including respiratory distress syndrome, jaundice, infections, and developmental delays. High birth weight babies may face challenges with delivery, increased risk of obesity, and potential metabolic issues later in life. Regular prenatal care is essential to monitor fetal growth and ensure a healthy pregnancy and optimal birth weight for the baby.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

A fetus is the developing offspring in a mammal, from the end of the embryonic period (approximately 8 weeks after fertilization in humans) until birth. In humans, the fetal stage of development starts from the eleventh week of pregnancy and continues until childbirth, which is termed as full-term pregnancy at around 37 to 40 weeks of gestation. During this time, the organ systems become fully developed and the body grows in size. The fetus is surrounded by the amniotic fluid within the amniotic sac and is connected to the placenta via the umbilical cord, through which it receives nutrients and oxygen from the mother. Regular prenatal care is essential during this period to monitor the growth and development of the fetus and ensure a healthy pregnancy and delivery.

Gestational age is the length of time that has passed since the first day of the last menstrual period (LMP) in pregnant women. It is the standard unit used to estimate the age of a pregnancy and is typically expressed in weeks. This measure is used because the exact date of conception is often not known, but the start of the last menstrual period is usually easier to recall.

It's important to note that since ovulation typically occurs around two weeks after the start of the LMP, gestational age is approximately two weeks longer than fetal age, which is the actual time elapsed since conception. Medical professionals use both gestational and fetal age to track the development and growth of the fetus during pregnancy.

Fetal growth retardation, also known as intrauterine growth restriction (IUGR), is a condition in which a fetus fails to grow at the expected rate during pregnancy. This can be caused by various factors such as maternal health problems, placental insufficiency, chromosomal abnormalities, and genetic disorders. The fetus may be smaller than expected for its gestational age, have reduced movement, and may be at risk for complications during labor and delivery. It is important to monitor fetal growth and development closely throughout pregnancy to detect any potential issues early on and provide appropriate medical interventions.

The placenta is an organ that develops in the uterus during pregnancy and provides oxygen and nutrients to the growing baby through the umbilical cord. It also removes waste products from the baby's blood. The placenta attaches to the wall of the uterus, and the baby's side of the placenta contains many tiny blood vessels that connect to the baby's circulatory system. This allows for the exchange of oxygen, nutrients, and waste between the mother's and baby's blood. After the baby is born, the placenta is usually expelled from the uterus in a process called afterbirth.

The third trimester of pregnancy is the final stage of pregnancy that lasts from week 29 until birth, which typically occurs around the 40th week. During this period, the fetus continues to grow and mature, gaining weight rapidly. The mother's body also prepares for childbirth by dilating the cervix and producing milk in preparation for breastfeeding. Regular prenatal care is crucial during this time to monitor the health of both the mother and the developing fetus, as well as to prepare for delivery.

Fetal macrosomia is a medical condition where the fetus in the womb is significantly larger than normal. While there is no consensus on an exact weight that defines macrosomia, it is generally defined as a fetus with an estimated weight of 4,000 grams (8 pounds 13 ounces) or more at birth.

Fetal macrosomia can be caused by several factors, including maternal diabetes, post-term pregnancy, excessive weight gain during pregnancy, and prior history of macrosomic infants. Macrosomic infants are at an increased risk for complications during labor and delivery, such as shoulder dystocia, birth injuries, and hypoglycemia.

It is important for healthcare providers to monitor fetal growth carefully during pregnancy, particularly in women who have risk factors for macrosomia. Regular prenatal care, including ultrasound measurements of the fetus, can help identify cases of fetal macrosomia and allow for appropriate management and delivery planning.

Weight gain is defined as an increase in body weight over time, which can be attributed to various factors such as an increase in muscle mass, fat mass, or total body water. It is typically measured in terms of pounds or kilograms and can be intentional or unintentional. Unintentional weight gain may be a cause for concern if it's significant or accompanied by other symptoms, as it could indicate an underlying medical condition such as hypothyroidism, diabetes, or heart disease.

It is important to note that while body mass index (BMI) can be used as a general guideline for weight status, it does not differentiate between muscle mass and fat mass. Therefore, an increase in muscle mass through activities like strength training could result in a higher BMI, but this may not necessarily be indicative of increased health risks associated with excess body fat.

Biometry, also known as biometrics, is the scientific study of measurements and statistical analysis of living organisms. In a medical context, biometry is often used to refer to the measurement and analysis of physical characteristics or features of the human body, such as height, weight, blood pressure, heart rate, and other physiological variables. These measurements can be used for a variety of purposes, including diagnosis, treatment planning, monitoring disease progression, and research.

In addition to physical measurements, biometry may also refer to the use of statistical methods to analyze biological data, such as genetic information or medical images. This type of analysis can help researchers and clinicians identify patterns and trends in large datasets, and make predictions about health outcomes or treatment responses.

Overall, biometry is an important tool in modern medicine, as it allows healthcare professionals to make more informed decisions based on data and evidence.

Embryonic and fetal development is the process of growth and development that occurs from fertilization of the egg (conception) to birth. The terms "embryo" and "fetus" are used to describe different stages of this development:

* Embryonic development: This stage begins at fertilization and continues until the end of the 8th week of pregnancy. During this time, the fertilized egg (zygote) divides and forms a blastocyst, which implants in the uterus and begins to develop into a complex structure called an embryo. The embryo consists of three layers of cells that will eventually form all of the organs and tissues of the body. During this stage, the basic structures of the body, including the nervous system, heart, and gastrointestinal tract, begin to form.
* Fetal development: This stage begins at the end of the 8th week of pregnancy and continues until birth. During this time, the embryo is called a fetus, and it grows and develops rapidly. The organs and tissues that were formed during the embryonic stage continue to mature and become more complex. The fetus also begins to move and kick, and it can hear and respond to sounds from outside the womb.

Overall, embryonic and fetal development is a complex and highly regulated process that involves the coordinated growth and differentiation of cells and tissues. It is a critical period of development that lays the foundation for the health and well-being of the individual throughout their life.

Weight loss is a reduction in body weight attributed to loss of fluid, fat, muscle, or bone mass. It can be intentional through dieting and exercise or unintentional due to illness or disease. Unintentional weight loss is often a cause for concern and should be evaluated by a healthcare professional to determine the underlying cause and develop an appropriate treatment plan. Rapid or significant weight loss can also have serious health consequences, so it's important to approach any weight loss plan in a healthy and sustainable way.

Litter size is a term used in veterinary medicine, particularly in relation to breeding of animals. It refers to the number of offspring that are born to an animal during one pregnancy. For example, in the case of dogs or cats, it would be the number of kittens or puppies born in a single litter. The size of the litter can vary widely depending on the species, breed, age, and health status of the parent animals.

"Animal pregnancy" is not a term that is typically used in medical definitions. However, in biological terms, animal pregnancy refers to the condition where a fertilized egg (or eggs) implants and develops inside the reproductive tract of a female animal, leading to the birth of offspring (live young).

The specific details of animal pregnancy can vary widely between different species, with some animals exhibiting phenomena such as placental development, gestation periods, and hormonal changes that are similar to human pregnancy, while others may have very different reproductive strategies.

It's worth noting that the study of animal pregnancy and reproduction is an important area of biological research, as it can provide insights into fundamental mechanisms of embryonic development, genetics, and evolution.

Organ size refers to the volume or physical measurement of an organ in the body of an individual. It can be described in terms of length, width, and height or by using specialized techniques such as imaging studies (like CT scans or MRIs) to determine the volume. The size of an organ can vary depending on factors such as age, sex, body size, and overall health status. Changes in organ size may indicate various medical conditions, including growths, inflammation, or atrophy.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

The umbilical arteries are a pair of vessels that develop within the umbilical cord during fetal development. They carry oxygenated and nutrient-rich blood from the mother to the developing fetus through the placenta. These arteries arise from the internal iliac arteries in the fetus and pass through the umbilical cord to connect with the two umbilical veins within the placenta. After birth, the umbilical arteries become ligaments (the medial umbilical ligaments) that run along the inner abdominal wall.

Anthropometry is the scientific study of measurements and proportions of the human body. It involves the systematic measurement and analysis of various physical characteristics, such as height, weight, blood pressure, waist circumference, and other body measurements. These measurements are used in a variety of fields, including medicine, ergonomics, forensics, and fashion design, to assess health status, fitness level, or to design products and environments that fit the human body. In a medical context, anthropometry is often used to assess growth and development, health status, and disease risk factors in individuals and populations.

Maternal-fetal exchange, also known as maternal-fetal transport or placental transfer, refers to the physiological process by which various substances are exchanged between the mother and fetus through the placenta. This exchange includes the transfer of oxygen and nutrients from the mother's bloodstream to the fetal bloodstream, as well as the removal of waste products and carbon dioxide from the fetal bloodstream to the mother's bloodstream.

The process occurs via passive diffusion, facilitated diffusion, and active transport mechanisms across the placental barrier, which is composed of fetal capillary endothelial cells, the extracellular matrix, and the syncytiotrophoblast layer of the placenta. The maternal-fetal exchange is crucial for the growth, development, and survival of the fetus throughout pregnancy.

Fetal nutrition disorders refer to conditions that occur when a fetus fails to receive adequate nutrients for proper growth and development during pregnancy. This can result from various factors, such as maternal malnutrition, placental insufficiency, or genetic abnormalities. Some examples of fetal nutrition disorders include intrauterine growth restriction (IUGR), small for gestational age (SGA), and birth defects related to nutrient deficiencies. These conditions can lead to a range of complications, including premature birth, low birth weight, developmental delays, and long-term health problems. It is essential to monitor fetal growth and nutrition during pregnancy to identify and manage these disorders early on.

Amniotic fluid is a clear, slightly yellowish liquid that surrounds and protects the developing baby in the uterus. It is enclosed within the amniotic sac, which is a thin-walled sac that forms around the embryo during early pregnancy. The fluid is composed of fetal urine, lung secretions, and fluids that cross over from the mother's bloodstream through the placenta.

Amniotic fluid plays several important roles in pregnancy:

1. It provides a shock-absorbing cushion for the developing baby, protecting it from injury caused by movement or external forces.
2. It helps to maintain a constant temperature around the fetus, keeping it warm and comfortable.
3. It allows the developing baby to move freely within the uterus, promoting normal growth and development of the muscles and bones.
4. It provides a source of nutrients and hydration for the fetus, helping to support its growth and development.
5. It helps to prevent infection by providing a barrier between the fetus and the outside world.

Throughout pregnancy, the volume of amniotic fluid increases as the fetus grows. The amount of fluid typically peaks around 34-36 weeks of gestation, after which it begins to gradually decrease. Abnormalities in the volume of amniotic fluid can indicate problems with the developing baby or the pregnancy itself, and may require medical intervention.

Fetal monitoring is a procedure used during labor and delivery to assess the well-being of the fetus. It involves the use of electronic devices to measure and record the fetal heart rate and uterine contractions. The information obtained from fetal monitoring can help healthcare providers identify any signs of fetal distress, such as a decreased fetal heart rate, which may indicate the need for interventions or an emergency cesarean delivery.

There are two main types of fetal monitoring: external and internal. External fetal monitoring involves placing sensors on the mother's abdomen to detect the fetal heart rate and uterine contractions. Internal fetal monitoring, which is typically used during high-risk deliveries, involves inserting an electrode into the fetus' scalp to measure the fetal heart rate more accurately.

Fetal monitoring can provide valuable information about the fetus's well-being during labor and delivery, but it is important to note that it has limitations and may not always detect fetal distress in a timely manner. Therefore, healthcare providers must use their clinical judgment and other assessment tools, such as fetal movement counting and visual examination of the fetus, to ensure the safe delivery of the baby.

The second trimester of pregnancy is the period between the completion of 12 weeks (the end of the first trimester) and 26 weeks (the beginning of the third trimester) of gestational age. It is often considered the most comfortable period for many pregnant women as the risk of miscarriage decreases significantly, and the symptoms experienced during the first trimester, such as nausea and fatigue, typically improve.

During this time, the uterus expands above the pubic bone, allowing more space for the growing fetus. The fetal development in the second trimester includes significant growth in size and weight, formation of all major organs, and the beginning of movement sensations that the mother can feel. Additionally, the fetus starts to hear, swallow and kick, and the skin is covered with a protective coating called vernix.

Prenatal care during this period typically includes regular prenatal appointments to monitor the mother's health and the baby's growth and development. These appointments may include measurements of the uterus, fetal heart rate monitoring, and screening tests for genetic disorders or other potential issues.

Fetal resorption, also known as fetal demise or intrauterine fetal death, is a medical term that refers to the absorption of a nonviable fetus by the mother's body after its death in utero. This process typically occurs before the 20th week of gestation and may go unnoticed if it happens early in pregnancy.

During fetal resorption, the fetal tissue is broken down and absorbed by the mother's body, leaving no visible remains of the fetus. The placenta and other surrounding tissues may still be present, but they often undergo changes as well. In some cases, a small amount of fetal tissue may be expelled from the uterus during the resorption process.

The causes of fetal resorption can vary, including chromosomal abnormalities, maternal health conditions, infections, and environmental factors. It is essential to seek medical attention if a woman suspects fetal resorption or experiences any unusual symptoms during pregnancy, such as vaginal bleeding or decreased fetal movement, to ensure proper diagnosis and management.

"Drug-induced abnormalities" refer to physical or physiological changes that occur as a result of taking medication or drugs. These abnormalities can affect various organs and systems in the body and can range from minor symptoms, such as nausea or dizziness, to more serious conditions, such as liver damage or heart rhythm disturbances.

Drug-induced abnormalities can occur for several reasons, including:

1. Direct toxicity: Some drugs can directly damage cells and tissues in the body, leading to abnormalities.
2. Altered metabolism: Drugs can interfere with normal metabolic processes in the body, leading to the accumulation of harmful substances or the depletion of essential nutrients.
3. Hormonal imbalances: Some drugs can affect hormone levels in the body, leading to abnormalities.
4. Allergic reactions: Some people may have allergic reactions to certain drugs, which can cause a range of symptoms, including rashes, swelling, and difficulty breathing.
5. Interactions with other drugs: Taking multiple medications or drugs at the same time can increase the risk of drug-induced abnormalities.

It is important for healthcare providers to monitor patients closely for signs of drug-induced abnormalities and to adjust medication dosages or switch to alternative treatments as necessary. Patients should also inform their healthcare providers of any symptoms they experience while taking medication, as these may be related to drug-induced abnormalities.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Pregnancy outcome refers to the final result or status of a pregnancy, including both the health of the mother and the newborn baby. It can be categorized into various types such as:

1. Live birth: The delivery of one or more babies who show signs of life after separation from their mother.
2. Stillbirth: The delivery of a baby who has died in the womb after 20 weeks of pregnancy.
3. Miscarriage: The spontaneous loss of a pregnancy before the 20th week.
4. Abortion: The intentional termination of a pregnancy before the fetus can survive outside the uterus.
5. Ectopic pregnancy: A pregnancy that develops outside the uterus, usually in the fallopian tube, which is not viable and requires medical attention.
6. Preterm birth: The delivery of a baby before 37 weeks of gestation, which can lead to various health issues for the newborn.
7. Full-term birth: The delivery of a baby between 37 and 42 weeks of gestation.
8. Post-term pregnancy: The delivery of a baby after 42 weeks of gestation, which may increase the risk of complications for both mother and baby.

The pregnancy outcome is influenced by various factors such as maternal age, health status, lifestyle habits, genetic factors, and access to quality prenatal care.

Twin pregnancy refers to a type of multiple pregnancy where a woman is carrying two fetuses simultaneously. There are two types of twin pregnancies: monozygotic (identical) and dizygotic (fraternal). Monoygotic twins occur when a single fertilized egg (zygote) splits and develops into two separate embryos, resulting in identical twins who share the same genetic material. Dizygotic twins, on the other hand, result from the fertilization of two separate eggs by two different sperm cells, leading to non-identical twins who have their own unique genetic material.

Twin pregnancies are associated with higher risks of complications compared to singleton pregnancies, including preterm labor, low birth weight, gestational diabetes, and preeclampsia. Close monitoring by healthcare providers is essential to ensure the best possible outcomes for both the mother and the twins.

Placental circulation refers to the specialized circulatory system that develops during pregnancy to allow for the exchange of nutrients, oxygen, and waste products between the mother's blood and the fetal blood in the placenta. The placenta is a highly vascular organ that grows within the uterus and is connected to the developing fetus via the umbilical cord.

In the maternal side of the placenta, the spiral arteries branch into smaller vessels called the intervillous spaces, where they come in close contact with the fetal blood vessels within the villi (finger-like projections) of the placenta. The intervillous spaces are filled with maternal blood that flows around the villi, allowing for the exchange of gases and nutrients between the two circulations.

On the fetal side, the umbilical cord contains two umbilical arteries that carry oxygen-depleted blood from the fetus to the placenta, and one umbilical vein that returns oxygenated blood back to the fetus. The umbilical arteries branch into smaller vessels within the villi, where they exchange gases and nutrients with the maternal blood in the intervillous spaces.

Overall, the placental circulation is a crucial component of fetal development, allowing for the growing fetus to receive the necessary oxygen and nutrients to support its growth and development.

Oligohydramnios is a medical condition that refers to an abnormally low amount of amniotic fluid surrounding the fetus in the uterus during pregnancy. The amniotic fluid is essential for the protection and development of the fetus, including lung maturation and joint mobility. Oligohydramnios is often diagnosed through ultrasound measurements of the pocket depth of the amniotic fluid and is defined as an amniotic fluid index (AFI) of less than 5 cm or a single deepest pocket (SDP) of less than 2 cm after 24 weeks of gestation.

The condition can be caused by various factors, such as fetal growth restriction, maternal high blood pressure, placental insufficiency, rupture of membranes, and genetic disorders. Oligohydramnios may increase the risk of complications during pregnancy and childbirth, including preterm labor, fetal distress, and stillbirth. The management of oligohydramnios depends on the underlying cause and gestational age, and may include close monitoring, delivery, or treatment of the underlying condition.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

The abdomen refers to the portion of the body that lies between the thorax (chest) and the pelvis. It is a musculo-fascial cavity containing the digestive, urinary, and reproductive organs. The abdominal cavity is divided into several regions and quadrants for medical description and examination purposes. These include the upper and lower abdomen, as well as nine quadrants formed by the intersection of the midline and a horizontal line drawn at the level of the umbilicus (navel).

The major organs located within the abdominal cavity include:

1. Stomach - muscular organ responsible for initial digestion of food
2. Small intestine - long, coiled tube where most nutrient absorption occurs
3. Large intestine - consists of the colon and rectum; absorbs water and stores waste products
4. Liver - largest internal organ, involved in protein synthesis, detoxification, and metabolism
5. Pancreas - secretes digestive enzymes and hormones such as insulin
6. Spleen - filters blood and removes old red blood cells
7. Kidneys - pair of organs responsible for filtering waste products from the blood and producing urine
8. Adrenal glands - sit atop each kidney, produce hormones that regulate metabolism, immune response, and stress response

The abdomen is an essential part of the human body, playing a crucial role in digestion, absorption, and elimination of food and waste materials, as well as various metabolic processes.

Fetal viability is the point in pregnancy at which a fetus is considered capable of surviving outside the uterus, given appropriate medical support. Although there is no precise gestational age that defines fetal viability, it is generally considered to occur between 24 and 28 weeks of gestation. At this stage, the fetus has developed sufficient lung maturity and body weight, and the risk of neonatal mortality and morbidity significantly decreases. However, the exact definition of fetal viability may vary depending on regional standards, medical facilities, and individual clinical assessments.

Crown-rump length (CRL) is a medical measurement used in obstetrics to estimate the age of a developing fetus. It refers to the length from the top of the head (crown) to the bottom of the buttocks (rump). This measurement is typically taken during an ultrasound examination in the first trimester of pregnancy, between 8 and 13 weeks of gestation.

The CRL is used to calculate the estimated due date and to monitor fetal growth and development. It can also help identify potential issues or abnormalities in fetal development. As the pregnancy progresses, other measurements such as head circumference, abdominal circumference, and femur length are used to assess fetal growth and development.

The parietal bone is one of the four flat bones that form the skull's cranial vault, which protects the brain. There are two parietal bones in the skull, one on each side, located posterior to the frontal bone and temporal bone, and anterior to the occipital bone. Each parietal bone has a squamous part, which forms the roof and sides of the skull, and a smaller, wing-like portion called the mastoid process. The parietal bones contribute to the formation of the coronal and lambdoid sutures, which are fibrous joints that connect the bones in the skull.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Teratogens are substances, such as certain medications, chemicals, or infectious agents, that can cause birth defects or abnormalities in the developing fetus when a woman is exposed to them during pregnancy. They can interfere with the normal development of the fetus and lead to a range of problems, including physical deformities, intellectual disabilities, and sensory impairments. Examples of teratogens include alcohol, tobacco smoke, some prescription medications, and infections like rubella (German measles). It is important for women who are pregnant or planning to become pregnant to avoid exposure to known teratogens as much as possible.

Prolonged pregnancy, also known as post-term pregnancy, is a medical condition defined as a pregnancy that continues beyond 42 weeks (294 days) of gestation from the first day of the last menstrual period. It is important to note that this definition is based on the estimated date of delivery and not the actual conception date. Prolonged pregnancies are associated with increased risks for both the mother and the fetus, including stillbirth, meconium aspiration, fetal distress, and difficulty during labor and delivery. Therefore, healthcare providers closely monitor pregnant women who reach 41 weeks of gestation to ensure timely delivery if necessary.

'Pregnancy in Diabetics' refers to the condition where an individual with pre-existing diabetes mellitus becomes pregnant. This can be further categorized into two types:

1. Pre-gestational diabetes: This is when a woman is diagnosed with diabetes before she becomes pregnant. It includes both Type 1 and Type 2 diabetes. Proper control of blood sugar levels prior to conception and during pregnancy is crucial to reduce the risk of complications for both the mother and the baby.

2. Gestational diabetes: This is when a woman develops high blood sugar levels during pregnancy, typically in the second or third trimester. While it usually resolves after delivery, women with gestational diabetes have a higher risk of developing Type 2 diabetes later in life. Proper management of gestational diabetes is essential to ensure a healthy pregnancy and reduce the risk of complications for both the mother and the baby.

I apologize, but "sheep" is not a term that has a medical definition. It is a common animal with the scientific name Ovis aries. If you have any medical or health-related questions, I would be happy to try and help answer those for you.

Polyhydramnios is a medical condition characterized by an excessive accumulation of amniotic fluid in the sac surrounding the fetus during pregnancy, typically defined as an amniotic fluid index (AFI) greater than 24 cm or a single deepest pocket (SDP) measurement of more than 8 cm. It occurs in approximately 1-2% of pregnancies and can be associated with various maternal, fetal, and genetic conditions. If left untreated, polyhydramnios may increase the risk of premature labor, premature rupture of membranes, and other pregnancy complications. Proper diagnosis and management are essential to ensure a healthy pregnancy outcome.

Small for Gestational Age (SGA) is a term used in pediatrics to describe newborn infants who are smaller in size than expected for the number of weeks they have been in the womb. It is typically defined as a baby whose weight is below the 10th percentile for its gestational age. SGA can be further classified into two categories: constitutionally small (also known as physiologically small) and pathologically small. Constitutionally small infants are those who are genetically predisposed to being smaller, while pathologically small infants have a growth restriction due to factors such as placental insufficiency, maternal hypertension, or chromosomal abnormalities.

It is important to note that SGA is not the same as premature birth. Premature babies are those born before 37 weeks of gestation, regardless of their size. However, a baby can be both premature and SGA.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

In medical terms, parity refers to the number of times a woman has given birth to a viable fetus, usually defined as a pregnancy that reaches at least 20 weeks' gestation. It is often used in obstetrics and gynecology to describe a woman's childbearing history and to assess potential risks associated with childbirth.

Parity is typically categorized as follows:

* Nulliparous: A woman who has never given birth to a viable fetus.
* Primiparous: A woman who has given birth to one viable fetus.
* Multiparous: A woman who has given birth to more than one viable fetus.

In some cases, parity may also consider the number of pregnancies that resulted in stillbirths or miscarriages, although this is not always the case. It's important to note that parity does not necessarily reflect the total number of pregnancies a woman has had, only those that resulted in viable births.

In the context of human anatomy, the thigh is the part of the lower limb that extends from the hip to the knee. It is the upper and largest portion of the leg and is primarily composed of the femur bone, which is the longest and strongest bone in the human body, as well as several muscles including the quadriceps femoris (front thigh), hamstrings (back thigh), and adductors (inner thigh). The major blood vessels and nerves that supply the lower limb also pass through the thigh.

Ultrasonography, also known as sonography, is a diagnostic medical procedure that uses high-frequency sound waves (ultrasound) to produce dynamic images of organs, tissues, or blood flow inside the body. These images are captured in real-time and can be used to assess the size, shape, and structure of various internal structures, as well as detect any abnormalities such as tumors, cysts, or inflammation.

During an ultrasonography procedure, a small handheld device called a transducer is placed on the patient's skin, which emits and receives sound waves. The transducer sends high-frequency sound waves into the body, and these waves bounce back off internal structures and are recorded by the transducer. The recorded data is then processed and transformed into visual images that can be interpreted by a medical professional.

Ultrasonography is a non-invasive, painless, and safe procedure that does not use radiation like other imaging techniques such as CT scans or X-rays. It is commonly used to diagnose and monitor conditions in various parts of the body, including the abdomen, pelvis, heart, blood vessels, and musculoskeletal system.

Reference values, also known as reference ranges or reference intervals, are the set of values that are considered normal or typical for a particular population or group of people. These values are often used in laboratory tests to help interpret test results and determine whether a patient's value falls within the expected range.

The process of establishing reference values typically involves measuring a particular biomarker or parameter in a large, healthy population and then calculating the mean and standard deviation of the measurements. Based on these statistics, a range is established that includes a certain percentage of the population (often 95%) and excludes extreme outliers.

It's important to note that reference values can vary depending on factors such as age, sex, race, and other demographic characteristics. Therefore, it's essential to use reference values that are specific to the relevant population when interpreting laboratory test results. Additionally, reference values may change over time due to advances in measurement technology or changes in the population being studied.

Placental insufficiency is a condition in which the placenta does not provide adequate nutrients and oxygen to the developing fetus. This can occur due to various reasons, such as poor placental development, damage to the placenta, or problems with the blood flow to the placenta. As a result, the fetus may receive less oxygen and nutrients than it needs for proper growth and development, which can lead to a range of complications, including low birth weight, preterm birth, and developmental delays.

The medical definition of placental insufficiency is: "a condition in which the placenta fails to provide adequate support to the developing fetus, resulting in impaired fetal growth and development." This condition can be diagnosed through various tests, such as ultrasound, fetal monitoring, and blood tests, and may require close monitoring and management throughout pregnancy to ensure the best possible outcomes for both the mother and the baby.

Fetal death, also known as stillbirth or intrauterine fetal demise, is defined as the death of a fetus at 20 weeks of gestation or later. The criteria for defining fetal death may vary slightly by country and jurisdiction, but in general, it refers to the loss of a pregnancy after the point at which the fetus is considered viable outside the womb.

Fetal death can occur for a variety of reasons, including chromosomal abnormalities, placental problems, maternal health conditions, infections, and umbilical cord accidents. In some cases, the cause of fetal death may remain unknown.

The diagnosis of fetal death is typically made through ultrasound or other imaging tests, which can confirm the absence of a heartbeat or movement in the fetus. Once fetal death has been diagnosed, medical professionals will work with the parents to determine the best course of action for managing the pregnancy and delivering the fetus. This may involve waiting for labor to begin naturally, inducing labor, or performing a cesarean delivery.

Experiencing a fetal death can be a very difficult and emotional experience for parents, and it is important for them to receive supportive care from their healthcare providers, family members, and friends. Grief counseling and support groups may also be helpful in coping with the loss.

Pregnancy complications refer to any health problems that arise during pregnancy which can put both the mother and the baby at risk. These complications may occur at any point during the pregnancy, from conception until childbirth. Some common pregnancy complications include:

1. Gestational diabetes: a type of diabetes that develops during pregnancy in women who did not have diabetes before becoming pregnant.
2. Preeclampsia: a pregnancy complication characterized by high blood pressure and damage to organs such as the liver or kidneys.
3. Placenta previa: a condition where the placenta covers the cervix, which can cause bleeding and may require delivery via cesarean section.
4. Preterm labor: when labor begins before 37 weeks of gestation, which can lead to premature birth and other complications.
5. Intrauterine growth restriction (IUGR): a condition where the fetus does not grow at a normal rate inside the womb.
6. Multiple pregnancies: carrying more than one baby, such as twins or triplets, which can increase the risk of premature labor and other complications.
7. Rh incompatibility: a condition where the mother's blood type is different from the baby's, which can cause anemia and jaundice in the newborn.
8. Pregnancy loss: including miscarriage, stillbirth, or ectopic pregnancy, which can be emotionally devastating for the parents.

It is important to monitor pregnancy closely and seek medical attention promptly if any concerning symptoms arise. With proper care and management, many pregnancy complications can be treated effectively, reducing the risk of harm to both the mother and the baby.

Fetal blood refers to the blood circulating in a fetus during pregnancy. It is essential for the growth and development of the fetus, as it carries oxygen and nutrients from the placenta to the developing tissues and organs. Fetal blood also removes waste products, such as carbon dioxide, from the fetal tissues and transports them to the placenta for elimination.

Fetal blood has several unique characteristics that distinguish it from adult blood. For example, fetal hemoglobin (HbF) is the primary type of hemoglobin found in fetal blood, whereas adults primarily have adult hemoglobin (HbA). Fetal hemoglobin has a higher affinity for oxygen than adult hemoglobin, which allows it to more efficiently extract oxygen from the maternal blood in the placenta.

Additionally, fetal blood contains a higher proportion of reticulocytes (immature red blood cells) and nucleated red blood cells compared to adult blood. These differences reflect the high turnover rate of red blood cells in the developing fetus and the need for rapid growth and development.

Examination of fetal blood can provide important information about the health and well-being of the fetus during pregnancy. For example, fetal blood sampling (also known as cordocentesis or percutaneous umbilical blood sampling) can be used to diagnose genetic disorders, infections, and other conditions that may affect fetal development. However, this procedure carries risks, including preterm labor, infection, and fetal loss, and is typically only performed when there is a significant risk of fetal compromise or when other diagnostic tests have been inconclusive.

The fetal heart is the cardiovascular organ that develops in the growing fetus during pregnancy. It starts to form around 22 days after conception and continues to develop throughout the first trimester. By the end of the eighth week of gestation, the fetal heart has developed enough to pump blood throughout the body.

The fetal heart is similar in structure to the adult heart but has some differences. It is smaller and more compact, with a four-chambered structure that includes two atria and two ventricles. The fetal heart also has unique features such as the foramen ovale, which is a hole between the right and left atria that allows blood to bypass the lungs, and the ductus arteriosus, a blood vessel that connects the pulmonary artery to the aorta and diverts blood away from the lungs.

The fetal heart is responsible for pumping oxygenated blood from the placenta to the rest of the body and returning deoxygenated blood back to the placenta for re-oxygenation. The rate of the fetal heartbeat is faster than that of an adult, typically ranging from 120 to 160 beats per minute. Fetal heart rate monitoring is a common method used during pregnancy and childbirth to assess the health and well-being of the developing fetus.

In the field of medicine, twins are defined as two offspring produced by the same pregnancy. They can be either monozygotic (identical) or dizygotic (fraternal). Monozygotic twins develop from a single fertilized egg that splits into two separate embryos, resulting in individuals who share identical genetic material. Dizygotic twins, on the other hand, result from the fertilization of two separate eggs by two different sperm cells, leading to siblings who share about 50% of their genetic material, similar to non-twin siblings.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

The femur is the medical term for the thigh bone, which is the longest and strongest bone in the human body. It connects the hip bone to the knee joint and plays a crucial role in supporting the weight of the body and allowing movement during activities such as walking, running, and jumping. The femur is composed of a rounded head, a long shaft, and two condyles at the lower end that articulate with the tibia and patella to form the knee joint.

Maternal nutritional physiological phenomena refer to the various changes and processes that occur in a woman's body during pregnancy, lactation, and postpartum periods to meet the increased nutritional demands and support the growth and development of the fetus or infant. These phenomena involve complex interactions between maternal nutrition, hormonal regulation, metabolism, and physiological functions to ensure optimal pregnancy outcomes and offspring health.

Examples of maternal nutritional physiological phenomena include:

1. Adaptations in maternal nutrient metabolism: During pregnancy, the mother's body undergoes various adaptations to increase the availability of essential nutrients for fetal growth and development. For instance, there are increased absorption and utilization of glucose, amino acids, and fatty acids, as well as enhanced storage of glycogen and lipids in maternal tissues.
2. Placental transfer of nutrients: The placenta plays a crucial role in facilitating the exchange of nutrients between the mother and fetus. It selectively transports essential nutrients such as glucose, amino acids, fatty acids, vitamins, and minerals from the maternal circulation to the fetal compartment while removing waste products.
3. Maternal weight gain: Pregnant women typically experience an increase in body weight due to the growth of the fetus, placenta, amniotic fluid, and maternal tissues such as the uterus and breasts. Adequate gestational weight gain is essential for ensuring optimal pregnancy outcomes and reducing the risk of adverse perinatal complications.
4. Changes in maternal hormonal regulation: Pregnancy is associated with significant changes in hormonal profiles, including increased levels of estrogen, progesterone, human chorionic gonadotropin (hCG), and other hormones that regulate various physiological functions such as glucose metabolism, appetite regulation, and maternal-fetal immune tolerance.
5. Lactation: Following childbirth, the mother's body undergoes further adaptations to support lactation and breastfeeding. This involves the production and secretion of milk, which contains essential nutrients and bioactive components that promote infant growth, development, and immunity.
6. Nutrient requirements: Pregnancy and lactation increase women's nutritional demands for various micronutrients such as iron, calcium, folate, vitamin D, and omega-3 fatty acids. Meeting these increased nutritional needs is crucial for ensuring optimal pregnancy outcomes and supporting maternal health during the postpartum period.

Understanding these physiological adaptations and their implications for maternal and fetal health is essential for developing evidence-based interventions to promote positive pregnancy outcomes, reduce the risk of adverse perinatal complications, and support women's health throughout the reproductive lifespan.

High-risk pregnancy is a term used to describe a situation where the mother or the fetus has an increased risk of developing complications during pregnancy, labor, delivery, or in the postpartum period. These risks may be due to pre-existing medical conditions in the mother, such as diabetes, hypertension, heart disease, kidney disease, autoimmune disorders, or infectious diseases like HIV/AIDS. Other factors that can contribute to a high-risk pregnancy include advanced maternal age (35 years and older), obesity, multiple gestations (twins, triplets, etc.), fetal growth restriction, placental issues, and a history of previous pregnancy complications or preterm labor.

High-risk pregnancies require specialized care and monitoring by healthcare professionals, often involving maternal-fetal medicine specialists, obstetricians, perinatologists, and neonatologists. Regular prenatal care, frequent checkups, ultrasound monitoring, and sometimes additional testing and interventions may be necessary to ensure the best possible outcomes for both the mother and the baby.

"Swine" is a common term used to refer to even-toed ungulates of the family Suidae, including domestic pigs and wild boars. However, in a medical context, "swine" often appears in the phrase "swine flu," which is a strain of influenza virus that typically infects pigs but can also cause illness in humans. The 2009 H1N1 pandemic was caused by a new strain of swine-origin influenza A virus, which was commonly referred to as "swine flu." It's important to note that this virus is not transmitted through eating cooked pork products; it spreads from person to person, mainly through respiratory droplets produced when an infected person coughs or sneezes.

Regression analysis is a statistical technique used in medicine, as well as in other fields, to examine the relationship between one or more independent variables (predictors) and a dependent variable (outcome). It allows for the estimation of the average change in the outcome variable associated with a one-unit change in an independent variable, while controlling for the effects of other independent variables. This technique is often used to identify risk factors for diseases or to evaluate the effectiveness of medical interventions. In medical research, regression analysis can be used to adjust for potential confounding variables and to quantify the relationship between exposures and health outcomes. It can also be used in predictive modeling to estimate the probability of a particular outcome based on multiple predictors.

These findings suggest that impaired fetal growth does not have effects on blood cholesterol levels that would have a material ... Birth weight and subsequent cholesterol levels: exploration of the "fetal origins" hypothesis JAMA. 2004 Dec 8;292(22):2755-64. ... Context: Inverse associations between birth weight and subsequent blood cholesterol levels have been used to support the "fetal ... the weighted estimate for the 11 studies was -1.89 mg/dL (-0.049 mmol/L) total cholesterol per kilogram birth weight compared ...
Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future ...
The fetal weight percentile calculator allows you to estimate your childs growth rate in comparison to the general population. ... log_{10}({\rm Fetal\ weight}). log10​(Fetal weight) means the fetal weight logarithm of the base of 10. ... log10​(Fetal weight)=1.3596−(0.00386⋅AC⋅FL) +(0.0064⋅HC)+(0.00061⋅BPD⋅AC)+(0.0424⋅AC)+(0.174⋅FL),​ ... What is the estimated fetal weight?. The estimated fetal weight is the babys weight at a specific time of the pregnancy. ...
Results: The odds ratio for the effect of an additional 500 g of birth weight on TSB ⩾342 μmol/l declined with increasing ... Conclusion: Higher birth weight predicts TSB ⩾342 μmol/l in 36-38 week infants, but not in infants ⩾39 weeks. Further research ... Methods: 105 384 newborns (⩾2000 g and ⩾36 weeks) were analysed, and the effect of higher birth weight on total serum bilirubin ... risk factor scoring system for prediction of hyperbilirubinaemia that assigned increased risk to infants of higher birth weight ...
Effects of epigenetic modulatory drugs on fetal alcohol induced changes in pituitary D2R mRNA levels, protein levels, pituitary ... Increases Pituitary WeightProlactinomasusceptibilityD 2R promoter methylationbinge alcohol drinkingplasma PRL levelsFetal ... Mean ± SEM values of pituitary D2R mRNA levels (A), pituitary weight (B) and plasma PRL levels (C) are shown in the histograms ... Effects of epigenetic modulatory drugs on fetal alcohol induced changes in pituitary D2R mRNA levels, protein levels, pituitary ...
This study aimed to determine the correlation between maternal weight gain in each trimester and fetal growth according to pre- ... reported that weight gain in the second and first trimesters of pregnancy is associated with fetal growth, whereas weight gain ... In twin pregnancy, regardless of pre-pregnant BMI, maternal weight gain affects fetal growth. Particularly, weight gain in the ... In the present study, especially in the normal weight group, the closer the neonatal weight to the weight gain in the second ...
Although low fetal birth weight is associated with singleton babies born after in-vitro fertilisation, a new prospective study ... Ovarian Stimulation Does Not Affect Fetal Birth Weight - reporting from 23rd Annual Conference of the European Society of Human ... Ovarian Stimulation Does Not Affect Fetal Birth Weight - reporting from 23rd Annual Conference of the European Society of Human ...
... and prediction of small-for-gestation age are often based on fetal abdominal circumference or estimated fetal weight (EFW). The ... Unconditional and conditional standards for monitoring fetal size and fetal growth in terms of abdominal circumference and EFW ... Fetal abdominal circumference showed a roughly linear trajectory from 18 to 36 weeks of gestation, while EFW showed an ... In the Growing Up in Singapore Towards healthy Outcome (GUSTO) birth cohort study in Singapore, fetal biometric measurements ...
Birth Rate Birth Weight Female Fetal Death Humans Infant, Low Birth Weight Infant, Newborn Infant Mortality Pregnancy Research ... "Effects of very low birth weights on fetal and neonatal mortality rates in Alabama." 104, no. 5 (1989). Goldenberg, R L et al ... 1989). Effects of very low birth weights on fetal and neonatal mortality rates in Alabama.. 104(5). Goldenberg, R L et al. " ... "Effects of very low birth weights on fetal and neonatal mortality rates in Alabama." vol. 104, no. 5, 1989. Export RIS Citation ...
Fetal/Infant Death Questionnaire. Live Birth Questionnaire - Weighted Frequencies. Public Use Codebook. Question Data Position ... Fetal/Infant Death Questionnaire - Weighted Frequencies. Public Use Codebook. Question Q1 Data Position: 1 [CASEID] LF CASEID ( ... Employment Information and Weight Stratum. This page last reviewed: Thursday, January 28, 2016 This information is provided as ... Questionnaire Administration And Weight Stratum. Provider Questionnaire Frequencies. Public Use Codebook. Data Position: 1 [ ...
Judith Brand and colleagues analyse associations between maternal smoking and fetal growth ... Associations with trajectories of estimated fetal weight (EFW) and individual fetal parameters (head circumference, femur ... Fetal growth assessment. Longitudinal fetal growth trajectory analyses were based on repeat fetal ultrasound and birth ... fetal weight was estimated using the Hadlock 1985 formula [23]: Anthropometric measurements at birth (HC and weight in both ...
Fetal growth restriction and low birth weight. *Congenital malformations like orofacial clefts ... Maternal exposure to secondhand smoke during pregnancy causes small reductions in birth weight and research suggests it may ... Smoking cessation during pregnancy reduces the effects of smoking on fetal growth. Cessation early in pregnancy eliminates the ... Maternal exposure to secondhand smoke during pregnancy causes small reductions in birth weight and research suggests it may ...
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. In: Nature Genetics. ... Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. / EGG Consortium. In: ... Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nature Genetics. 2019 ... N2 - Birth weight variation is influenced by fetal and maternal genetic and non-genetic factors, and has been reproducibly ...
A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight.. Kiserud, Torvid; Piaggio, ... Correction: The World Health Organization Fetal Growth Charts: ...
... of the fetal weight 80% of the time. However, 20% of the time, the estimation of the fetal weight may be discrepant by more ... Fetal weight below the 10th percentile has a negative predictive value of 99%, a sensitivity of 89%, and a specificity of 88% ... If the estimated fetal weight is below the 10th percentile for gestational age, they suggest that further evaluation be ... Hadlock charts can be used to calculate the fetal weight from the AC. [19] Most ultrasonography machines also use the Hadlock ...
You can calculate fetal weight for free and read about fetal weight by week here. ... Do you want to know weight of your baby? ... Fetal Weight by Week. Fetal Weight Calculator - Fetal Weight by ... How to use the Fetal Weight Calculator?. Calculating fetal weight is very simple with our Fetal Weight Calculator. Just look at ... What if fetal weight deviates from the average fetal weight?. If an ultrasound shows that the weight of your baby deviates from ...
... ultrasound estimates of fetal weight from two time points in combination with birth weight. Models were stratified to ... Also in males, we noted inverse associations between average triclosan exposure over pregnancy and estimated fetal weight ... These associations were observed in models that included repeated ultrasound estimates of fetal weight during gestation as well ... Fetal growth; Birth weight; Growth restriction; Ultrasound; Anthropometry ...
... defined as estimated fetal weight ,10th percentile), and large for gestational age (defined as estimated fetal weight ,95th ... International estimated fetal weight standards of the INTERGROWTH-21st Project. Ultrasound Obstet Gynecol. 2017;49:478-86. DOI ... Di Mascio D, Sen C, Saccone G, Galindo A, Grünebaum A, Yoshimatsu J, et al. Risk factors associated with adverse fetal outcomes ... Stirnemann J, Villar J, Salomon LJ, Ohuma E, Ruyan P, Altman DG, et al.; International Fetal and Newborn Growth Consortium for ...
The most severe is fetal alcohol syndrome. Learn the risks and more. ... Drinking alcohol while pregnant can result in fetal alcohol spectrum disorders. ... Low body weight. *Poor coordination. *Hyperactive behavior. *Difficulty with attention and memory ... Fetal alcohol syndrome (FAS) is the most serious type of FASD. People with fetal alcohol syndrome have facial abnormalities, ...
Severe intrauterine growth restriction in which the estimated fetal weight is less than 5% ... In addition, fetal growth determination at 2-week intervals must be performed to document adequate fetal growth. A 24-hour ... Severe intrauterine growth restriction in which the estimated fetal weight is less than 5% ... During this period, maternal and fetal evaluation must show that the fetus does not have severe growth restriction or fetal ...
Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A (July 2013). "Gestational age and maternal weight effects on fetal cell ... Cell-free fetal DNA (cffDNA) is fetal DNA that circulates freely in the maternal blood. Maternal blood is sampled by ... Allyse M, Sayres LC, King JS, Norton ME, Cho MK (November 2012). "Cell-free fetal DNA testing for fetal aneuploidy and beyond: ... New evidence shows that cffDNA test failure rate is higher, fetal fraction (proportion of fetal versus maternal DNA in the ...
Fetal ovarian cysts can be suspected when an ultrasound scan shows intra-abdominal structures in female fetuses in the presence ... Current information regarding the treatment of fetal ovarian cysts is based on personal experiences and some case series. The ... Estimation of fetal weight with the use of head, body, femur measurements - a prospective study. Am J Obstet Gynecol. 1985;151: ... Transient ascites associated with a fetal ovarian cyst. Case report. Fetal Diagn Ther. 1995;10:200-3.10.1159/000264236Search in ...
... the average discrepancy between estimated and actual fetal weights; the correlation between estimated and actual fetal weights ... the average discrepancy between estimated and actual fetal weights; the correlation between estimated and actual fetal weights ... the average discrepancy between estimated and actual fetal weights; the correlation between estimated and actual fetal weights ... the average discrepancy between estimated and actual fetal weights; the correlation between estimated and actual fetal weights ...
Bipolar disorder, birth weight, fetal growth, lithium, pregnancy Persistent URL doi.org/10.1177/0269881120940914, hdl.handle. ... Lithium exposure during pregnancy increases fetal growth. Publication. Publication. Journal of Psychopharmacology ... pregnancy was associated with increased fetal growth parameters at 18-22 weeks gestational age and increased birth weight. ... Aims: To investigate the impact of lithium exposure on early fetal growth. Methods: In this retrospective observational cohort ...
There was no difference in fetal weight at gestational day 130. Interestingly, gestational length in this cohort was ... Fetal skeletal muscle ex vivo glucose uptake. Muscle strips from male and female fetal offspring at g130 from dams on CON or ... Fetal skeletal muscle ex vivo glucose uptake. Muscle strips from male and female fetal offspring at g130 from dams on CON or ... Fetal and Juvenile Tissue Collection and Ex Vivo 2-Deoxyglucose Uptake. After euthanasia, fetal g130 and 14-month-old offspring ...
The initial fetal weight estimation with a cutoff weight of 1080 g had the highest sensitivity (83.3%) and negative predictive ... The initial fetal weight estimation with a cutoff weight of 1283 g provided the best correct prediction of major morbidity ( ... For the short-term outcome measures assessed in this study, the estimated fetal weight at the time of diagnosis is the most ... Logistic regression showed the best overall predictive model for poor outcome to be a combination of initial fetal weight ...
Urine of pregnant women could be used to predict fetal growth and birth weight. "…Dr Mireille Toledano, co-lead author of the ... a panel of 10 urinary metabolites in the 3rd trimester of pregnancy that were associated with greater fetal growth and. ...
We use cookies to ensure that we give you the best experience on our website. If you click Accept all cookies well assume that you are happy to receive all cookies and you wont see this message again. If you click Reject all non-essential cookies only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click Find out more for information on how to change your cookie settings. ...

No FAQ available that match "fetal weight"

No images available that match "fetal weight"